Elanco Animal Health (XTRA:5EA) has seen its one-year price target revised to €22.07 per share, marking a 16.14% increase from the previous estimate of €19.01 on October 29, 2025. Analysts’ targets range from a low of €18.83 to a high of €26.69, indicating an 18.40% potential rise from the latest closing price of €18.64.
Currently, 758 funds and institutions report positions in Elanco, reflecting a 1.34% increase in ownership over the last quarter. Total institutional shares owned have risen by 4.87% to 702,094K shares, with an average portfolio weight of 0.22%, up by 4.00%. Notably, T. Rowe Price Investment Management increased its allocation by 120.00%, while Dodge & Cox slightly decreased their holdings by 0.16%.
